rs755760670
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003184.4(TAF2):c.3578G>A(p.Arg1193His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003184.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF2 | ENST00000378164.7 | c.3578G>A | p.Arg1193His | missense_variant | Exon 26 of 26 | 1 | NM_003184.4 | ENSP00000367406.2 | ||
TAF2 | ENST00000686879.1 | c.3734G>A | p.Arg1245His | missense_variant | Exon 27 of 27 | ENSP00000509206.1 | ||||
TAF2 | ENST00000685235.1 | c.3623G>A | p.Arg1208His | missense_variant | Exon 26 of 26 | ENSP00000510174.1 | ||||
TAF2 | ENST00000688645.1 | c.3467G>A | p.Arg1156His | missense_variant | Exon 25 of 25 | ENSP00000509978.1 | ||||
TAF2 | ENST00000523904.2 | c.3464G>A | p.Arg1155His | missense_variant | Exon 25 of 25 | 3 | ENSP00000430832.2 | |||
TAF2 | ENST00000690144 | c.*709G>A | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000510548.1 | |||||
TAF2 | ENST00000685202.1 | n.*1103G>A | non_coding_transcript_exon_variant | Exon 27 of 27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2970G>A | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3450G>A | non_coding_transcript_exon_variant | Exon 28 of 28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*5045G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3279G>A | non_coding_transcript_exon_variant | Exon 24 of 24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3296G>A | non_coding_transcript_exon_variant | Exon 27 of 27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3393G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2223G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2997G>A | non_coding_transcript_exon_variant | Exon 23 of 23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3185G>A | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2814G>A | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1990G>A | non_coding_transcript_exon_variant | Exon 26 of 26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3234G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3444G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3446G>A | non_coding_transcript_exon_variant | Exon 28 of 28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2965G>A | non_coding_transcript_exon_variant | Exon 25 of 25 | ENSP00000509603.1 | |||||
TAF2 | ENST00000685202.1 | n.*1103G>A | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2970G>A | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3450G>A | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*5045G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3279G>A | 3_prime_UTR_variant | Exon 24 of 24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3296G>A | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3393G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2223G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2997G>A | 3_prime_UTR_variant | Exon 23 of 23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3185G>A | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2814G>A | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1990G>A | 3_prime_UTR_variant | Exon 26 of 26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3234G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3444G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3446G>A | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2965G>A | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000509603.1 | |||||
TAF2 | ENST00000689164.1 | n.*4196G>A | downstream_gene_variant | ENSP00000508729.1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251180Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135750
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727238
GnomAD4 genome AF: 0.000177 AC: 27AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74318
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.3578G>A (p.R1193H) alteration is located in exon 26 (coding exon 26) of the TAF2 gene. This alteration results from a G to A substitution at nucleotide position 3578, causing the arginine (R) at amino acid position 1193 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 2508650). This variant has not been reported in the literature in individuals affected with TAF2-related conditions. This variant is present in population databases (rs755760670, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1193 of the TAF2 protein (p.Arg1193His). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at